Neuland Laboratories reported a strong performance in Mar-26, driven by robust revenue growth and significant margin expansion. Revenue grew sharply both YoY and QoQ, while EBITDA and net profit increased substantially due to improved operating leverage and cost efficiency. Despite higher operating expenses, profitability improved across all levels. Overall, the company delivered healthy earnings growth and strengthened its financial performance.
#NeulandLaboratories #Q4FY26 #EarningsGrowth #MarginExpansion #StrongPerformance